TeselaGen
TeselaGen provides an AI-enabling platform for biological R&D, designed to connect biological data, streamline experimental design, orchestrate workflows, and train AI models for breakthrough discoveries. Their comprehensive software suite includes tools for documenting experiments, uploading sequences, generating combinatorial DNA libraries, aligning and partitioning sequences, and automating DNA assembly. The platform also features inventory and equipment management, automated worklist generation for lab automation, and advanced tools for optimizing and analyzing experiments through AI-driven analytics. TeselaGen aims to replace costly traditional methods in biotech product development across pharma, ag-tech, and industrial biotech, enabling faster development of high-performance bio-based products. Notable customer impacts include a 7-fold increase in design & build speed and a 10-fold reduction in development costs.
TeselaGen
TeselaGen provides an AI-enabling platform for biological R&D, designed to connect biological data, streamline experimental design, orchestrate workflows, and train AI models for breakthrough discoveries. Their comprehensive software suite includes tools for documenting experiments, uploading sequences, generating combinatorial DNA libraries, aligning and partitioning sequences, and automating DNA assembly. The platform also features inventory and equipment management, automated worklist generation for lab automation, and advanced tools for optimizing and analyzing experiments through AI-driven analytics. TeselaGen aims to replace costly traditional methods in biotech product development across pharma, ag-tech, and industrial biotech, enabling faster development of high-performance bio-based products. Notable customer impacts include a 7-fold increase in design & build speed and a 10-fold reduction in development costs.
TL;DR
Company: TeselaGen — AI-enabled cloud platform for biological R&D
Founded: 2011
Headquarters: San Francisco Bay Area / Portola Valley, CA
Industry: Biotechnology
Notable funding: NSF SBIR awards (2014, 2017); most-recent Non-equity Assistance round Aug 24, 2023
Company Overview
Problem Domain
Streamlining and automating molecular design, laboratory workflows, and R&D data integration to speed biotechnology product development.
Founded
2011
Industry
Biotechnology
Tech Stack
Funding Track Record
750000
NSF SBIR Phase II award
500000
SBIR Phase IIB award
Most-recent non-equity assistance round
Investor Signal
“Endeavor Miami and WeBoost listed among investors; company has received NSF SBIR funding and other investors have included Propel(X), Taram Capital, and WeBoost.”